380 related articles for article (PubMed ID: 10514956)
1. Controversial aspects of hormone replacement therapy upon cardiovascular mortality and morbidity of women in menopause.
Rosano GM; Mercuro G
G Ital Cardiol; 1999 Sep; 29(9):999-1003. PubMed ID: 10514956
[No Abstract] [Full Text] [Related]
2. Comparative cardiovascular effects of different progestins in menopause.
Rosano GM; Fini M
Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
[TBL] [Abstract][Full Text] [Related]
3. [Coronary disease in women].
García-Palmieri MR; Perea-López RM
P R Health Sci J; 1996 Dec; 15(4):283-8. PubMed ID: 9190622
[TBL] [Abstract][Full Text] [Related]
4. Postmenopausal hormone therapy offers no protection against heart attacks.
American Medical Association
Ginecol Obstet Mex; 2002 Aug; 70():404-5. PubMed ID: 12448045
[No Abstract] [Full Text] [Related]
5. Lessons from hormone replacement therapy trials for primary prevention of cardiovascular disease.
Mohandas B; Mehta JL
Curr Opin Cardiol; 2007 Sep; 22(5):434-42. PubMed ID: 17762545
[TBL] [Abstract][Full Text] [Related]
6. Hormone replacement therapy (HRT) and ischaemic heart disease: getting to the heart of the matter.
Chew S; Ng SC
Singapore Med J; 2002 Jan; 43(1):41-4. PubMed ID: 12008777
[TBL] [Abstract][Full Text] [Related]
7. [Hormone replacement therapy of menopause, heart and blood vessels].
Kuttenn F; Gerson M
Arch Mal Coeur Vaiss; 2001 Jul; 94(7):685-9. PubMed ID: 11494629
[TBL] [Abstract][Full Text] [Related]
8. Postmenopausal estrogen and cardiovascular disease.
Stampfer MJ; Grodstein F; Bechtel S
Contemp Intern Med; 1994 Sep; 6(9):47-56, 59. PubMed ID: 10150308
[TBL] [Abstract][Full Text] [Related]
9. Estrogens, lipids, and heart disease.
Barrett-Connor E; Miller V
Clin Geriatr Med; 1993 Feb; 9(1):57-67. PubMed ID: 8443740
[TBL] [Abstract][Full Text] [Related]
10. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
Banks E; Canfell K
Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
[TBL] [Abstract][Full Text] [Related]
11. Baseline characteristics of menopausal women with coronary heart disease in cardiovascular outcomes clinical trials of menopausal hormone therapy or raloxifene.
Wenger NK; Geiger MJ
Contemp Clin Trials; 2005 Dec; 26(6):612-5. PubMed ID: 16257585
[TBL] [Abstract][Full Text] [Related]
12. Menopause and the risk of coronary heart disease in women.
Colditz GA; Willett WC; Stampfer MJ; Rosner B; Speizer FE; Hennekens CH
N Engl J Med; 1987 Apr; 316(18):1105-10. PubMed ID: 3574358
[TBL] [Abstract][Full Text] [Related]
13. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
Windler E; Zyriax BC; Eidenmüller B; Boeing H
Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
[TBL] [Abstract][Full Text] [Related]
14. Hormone therapy and selective estrogen receptor modulators for prevention of coronary heart disease in postmenopausal women estrogen replacement from the cardiologist's perspective.
Mobasseri S; Liebson PR; Klein LW
Cardiol Rev; 2004; 12(6):287-98. PubMed ID: 15476565
[TBL] [Abstract][Full Text] [Related]
15. [Hormone replacement therapy of menopause in women with vascular risk factors].
Charbonnel B
Diabete Metab; 1993; 19(4):387-90. PubMed ID: 8293865
[No Abstract] [Full Text] [Related]
16. Statement on results of the HERS II trial on hormone replacement therapy.
American College of Obstetricians and Gynecologists
Ginecol Obstet Mex; 2002 Aug; 70():406-8. PubMed ID: 12448046
[No Abstract] [Full Text] [Related]
17. Estrogens should not be initiated for the secondary prevention of coronary artery disease: a debate.
Hulley S
Can J Cardiol; 2000 Aug; 16 Suppl E():10E-12E. PubMed ID: 10906618
[TBL] [Abstract][Full Text] [Related]
18. Patterns of hormone replacement therapy in a population-based cohort of postmenopausal German women. Changes after HERS II and WHI.
Clanget C; Hinke V; Lange S; Fricke R; Botko R; Pfeilschifter J
Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):529-33. PubMed ID: 16235155
[TBL] [Abstract][Full Text] [Related]
19. Postmenopausal hormone replacement therapy: does the progestin make a difference?
Fylstra DL
J S C Med Assoc; 2002 Feb; 98(1):12-9. PubMed ID: 11859600
[No Abstract] [Full Text] [Related]
20. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
